| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
72,391 |
55,413 |
$5.65M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
75,624 |
54,532 |
$3.78M |
| 99199 |
Unlisted special service, procedure or report |
483,963 |
286,747 |
$2.91M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
22,981 |
16,474 |
$1.61M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
20,559 |
15,350 |
$1.50M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
14,477 |
11,301 |
$1.11M |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
30,795 |
22,278 |
$929K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
8,919 |
6,628 |
$718K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
42,338 |
30,627 |
$658K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,284 |
2,985 |
$474K |
| D0145 |
Oral evaluation for a patient under three years of age |
14,136 |
11,318 |
$436K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
30,790 |
22,811 |
$238K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,894 |
6,532 |
$235K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
19,480 |
7,385 |
$210K |
| D1206 |
Topical application of fluoride varnish |
14,264 |
11,388 |
$193K |
| 99401 |
|
8,282 |
5,262 |
$193K |
| 99460 |
|
2,305 |
2,015 |
$154K |
| 99215 |
Prolong outpt/office vis |
1,361 |
1,070 |
$150K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,095 |
16,123 |
$148K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12,682 |
9,815 |
$138K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,669 |
1,386 |
$135K |
| 87428 |
|
2,342 |
2,173 |
$134K |
| 99051 |
|
5,521 |
4,514 |
$120K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
958 |
871 |
$50K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,500 |
974 |
$42K |
| 90474 |
|
2,811 |
2,007 |
$40K |
| 83655 |
|
3,490 |
2,530 |
$38K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,416 |
1,544 |
$32K |
| 90651 |
|
3,929 |
2,718 |
$29K |
| 92551 |
|
24,675 |
18,510 |
$27K |
| 87081 |
|
4,161 |
3,389 |
$24K |
| 99462 |
|
776 |
619 |
$22K |
| 99173 |
|
33,547 |
25,167 |
$18K |
| 96161 |
|
6,406 |
4,839 |
$18K |
| 87807 |
|
1,767 |
1,273 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,070 |
722 |
$18K |
| 96127 |
|
4,383 |
3,617 |
$17K |
| 99050 |
|
873 |
699 |
$16K |
| 99441 |
|
495 |
401 |
$12K |
| 99381 |
|
111 |
94 |
$10K |
| 90670 |
|
15,802 |
11,129 |
$10K |
| 90734 |
|
2,365 |
1,611 |
$10K |
| 88720 |
|
1,852 |
1,333 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
793 |
653 |
$8K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
246 |
223 |
$8K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
192 |
25 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
540 |
377 |
$6K |
| 81001 |
|
2,098 |
1,518 |
$6K |
| 54160 |
|
58 |
44 |
$5K |
| 0071A |
|
144 |
86 |
$5K |
| 0072A |
|
93 |
83 |
$4K |
| 99463 |
|
43 |
36 |
$4K |
| 90620 |
|
447 |
336 |
$4K |
| 90633 |
|
8,008 |
5,834 |
$3K |
| 90723 |
|
13,003 |
9,398 |
$2K |
| 54150 |
|
14 |
12 |
$2K |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
907 |
659 |
$2K |
| 0002A |
|
41 |
35 |
$2K |
| 0001A |
|
65 |
32 |
$2K |
| 81003 |
|
908 |
607 |
$2K |
| 99442 |
|
53 |
25 |
$1K |
| A7015 |
Aerosol mask, used with dme nebulizer |
821 |
649 |
$1K |
| 90686 |
|
2,925 |
1,970 |
$1K |
| 90710 |
|
1,940 |
1,441 |
$1K |
| G9919 |
Screening performed and positive and provision of recommendations |
60 |
33 |
$1K |
| 90715 |
|
581 |
374 |
$559.80 |
| 81025 |
|
88 |
62 |
$501.63 |
| 2014F |
|
26 |
26 |
$280.00 |
| 96380 |
|
16 |
16 |
$274.18 |
| 90681 |
|
6,010 |
4,292 |
$273.40 |
| 90707 |
|
465 |
351 |
$240.02 |
| 90473 |
|
12 |
12 |
$225.10 |
| 96160 |
|
327 |
204 |
$177.93 |
| 90716 |
|
209 |
141 |
$160.02 |
| 90696 |
|
712 |
520 |
$113.87 |
| 90647 |
|
12,872 |
9,304 |
$87.58 |
| 82962 |
|
24 |
24 |
$68.44 |
| 90656 |
|
513 |
491 |
$60.78 |
| 94760 |
|
494 |
330 |
$19.92 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
120 |
105 |
$8.53 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
148 |
90 |
$5.35 |
| 90677 |
|
1,471 |
1,414 |
$3.26 |
| J7510 |
Prednisolone oral, per 5 mg |
15 |
12 |
$0.48 |
| 90660 |
|
47 |
46 |
$0.18 |
| 90697 |
|
56 |
56 |
$0.01 |
| 90700 |
|
613 |
486 |
$0.00 |
| 99072 |
|
164 |
128 |
$0.00 |
| 90688 |
|
1,127 |
861 |
$0.00 |
| 99000 |
|
121 |
78 |
$0.00 |